Information  X 
Enter a valid email address

ThromboGenics NV (0G99)

  Print   

Monday 18 September, 2017

ThromboGenics NV

ThromboGenics NV : ThromboGenics Regains Global Rights to JETREA® (ocriplasmin)

YASTEST

a d v e r t i s e m e n t